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ABSTRACT
Array based DNA pooling techniques facilitate
genome-wide scale genotyping of large samples.
We describe a structured analysis method for
pooled data using internal replication information
in large scale genotyping sets. The method takes
advantage of information from single nucleotide
polymorphisms (SNPs) typed in parallel on a high
density array to construct a test statistic with desir-
able statistical properties. We utilize a general linear
model to appropriately account for the structured
multiple measurements available with array data.
The method does not require the use of additional
arrays for the estimation of unequal hybridization
rates and hence scales readily to accommodate
arrays with several hundred thousand SNPs. Tests
for differences between cases and controls can be
conducted with very few arrays. We demonstrate the
method on 384 endometriosis cases and controls,
typedusingAffymetrixGenechip HindIII50Karrays.
For a subset of this data there were accurate meas-
ures of hybridization rates available. Assuming equal
hybridization rates is shown to have a negligible
effect upon the results. With a total of only six arrays,
the method extracted one-third of the information (in
terms of equivalent sample size) available with indi-
vidual genotyping (requiring 768 arrays). With 20
arrays (10 for cases, 10 for controls), over half of
the information could be extracted from this sample.
INTRODUCTION
Genome-wide genetic association analysis is set to
become one of the primary tools for the identiﬁcation of
loci contributing to susceptibility to complex common
human disease. However, the cost remains prohibitively
expensive for many projects. Genome scans of suitable
size (hundreds of cases/controls, hundreds of thousands of
markers) typically cost well over US$1 million. Instead of
genotyping the large numbers of markers [typically single
nucleotide polymorphisms or (SNPs)] in individual samples
on DNA microarrays, a number of authors have proposed
pooling the DNA from large numbers of individuals (1–3).
The pooled DNA is hybridized to arrays, such as the Affy-
metrix Genechip  array (4) and the allele frequencies estim-
ated in each pool. In practice, the primary interest is in tests of
the difference in allele frequency between the case pool and
the control pool. Whilst pooling offers a substantial reduction
in genotyping cost, naive tests derived from DNA pool allele
frequency estimates have undesirable statistical properties (5).
A more appropriate test can be derived by recognizing that
DNA pools yield estimated allele counts rather than observed
counts. Essentially, the additional variance generated by pool-
ing speciﬁc errors must be appropriately taken into account.
We propose a method for analysis of large scale pooling
data which utilizes the information available across multiple
SNPs to estimate the errors inherent in pooling. By utilizing
the information frommultipleSNPs weare abletoestimate the
variance associated with pooling. This allows us to construct a
statistical test for association with desirable properties. More-
over, since array data will typically have a regular structure
(in terms of multiple measurements per SNP on the array),
simple tests (such as t-tests) which ignore this structure will be
unsatisfactory. We propose the use of general linear model
based tests which take into account the structure of the array
data. Since the error variance associated with pooling is estim-
ated across SNPs, the need for replication of pools is minim-
ized, thereby decreasing cost. The method does not require
prior information on the value of k (a measure of the extent of
unequal ampliﬁcation/hybridization of alleles) and hence
avoids the need for expensive individual genotyping of het-
erozygotes for every SNP of interest. Therefore our method
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doi:10.1093/nar/gkl136easily scales up to arrays with hundreds of thousands to mil-
lions of SNPs. The new method is applied to data on a set of
384 cases and controls from a study on endometriosis (6–8)
typed with the Affymetrix Genechip  HindIII array (4). For a
subset of this data there were accurate measures of k available.
We show that assuming k ¼ 1 has a negligible effect upon the
results.
MATERIALS AND METHODS
Statistical methods
Pooling tests of association. In genetic association analysis the
primary interest is to estimate the difference in the proportion
of A alleles between case and control pools. The simplest test
for this difference at a SNP involves calculating the average
proportion in cases and controls and computing the test
statistic.
Tsimple ¼
ð~ p pa   ~ p puÞ
2
varð^ p pa  ^ p puÞ
’
ð~ p pa  ~ p puÞ
2
varð~ p pa   ~ p puÞ
1
The population frequency in cases is denoted pa, the pooling
sample estimate of the allele frequency is denoted ~ p pa and the
sample estimate if the sample was individually genotyped
without error is denoted ^ p pa. pu, ~ p pu and ^ p pu are deﬁned similarly
for controls. Since the values of ^ p pa and ^ p pu are not available the
sample estimates are used as an approximation in the denom-
inator of equation 1. In the absence of errors in the estimation
of ~ p pa and ~ p pu,v a r ð~ p pa   ~ p puÞ is given by the usual formula for the
binomial sampling variance, V ¼ pa(1   pa)/2na+pu(1   pu)/
2nu (or in practice ~ V V where the V is given a   to reﬂect the fact
it is based on sample estimates). The number of cases and
controls is na and nu, respectively. Tsimple will then have a c2
1
distribution (under the null hypothesis of no difference). How-
ever, in the presence of errors in the estimation of ~ p pa and
~ p pu, the term varð~ p pa   ~ p puÞ will be greater than ~ V V and the
distribution of Tsimple will no longer be c2
1 (5).
Denoting the variance of the pool speciﬁc error in
allele frequency estimation as var(epool 1), it is shown in
appendix 1 that a corrected test statistic is
T1 ¼ Tsimple ·
~ V V
~ V V þ 2varðepool 1Þ
2
The problem is hence to estimate var(epool 1). This could be
estimated from replicate pools for the SNPs in question but to
obviate the need for further genotyping we propose using the
full set of available SNPs to estimate var(epool 1). Before
doing that, we ﬁrst describe an efﬁcient means of estimating
the difference between cases and controls with array data.
A general linear model for array data. When arrays are used
for pooling there are typically multiple probe measurements
available. With Affymetrix Genechip  arrays there is a meas-
ure on each strand of the DNA (strand replication), several
measures (up to 7 with the 50 K chips) at different probe
positions on the chip (probe replication) and, typically, mul-
tiple arrays per sample (array replication). Arrays from other
manufacturers can be accommodated in our method by simple
modiﬁcation of the model to reﬂect the different structure of
replicated measurements. Although t-tests can be applied to
these multiple measurements, a more efﬁcient way of dealing
with this data is to explicitly model the data structure. To do
this we propose ﬁtting a general linear mixed model (GLMM).
An introduction to mixed models (models with both ﬁxed and
random effects) is given in Armitage (9). In the linear model
the response variable is the estimates of proportion of A alleles
in cases for a given SNP; this is calculated using p ¼ A/(A + B)
where A and B are measures of the ﬂuorescent intensities for
alleles A and B, respectively. Note that no correction is made
for unequal hybridization of the alleles, see also Data applica-
tion and Discussion sections below. Since there are multiple
probe measurements there are multiple measures of p. Let pijlm
denote the mth probe measure of p on strand l of replicate j in
sample i. With C samples (e.g. case, control), R array replic-
ates, S strand measures and D probe measures, and the vector
p will contain up to C · R · S · D values per SNP. Here we
consider two possible linear models; a nested (or hierarchical)
model and a non-nested model. The nested model for a
measure pijkl is
pijlm ¼ ci þ rj þ sjl þ dijlm:
This model nests the strand measures within replicates.
The predictor variables on the right hand side of the linear
model are a factor for case/control status ci, a factor for array
replicate rj,a factor for strand sjland a factor for probe position
dijlm.
An alternative, non-nested model is
pijlm ¼ ci þ rj þ sl þ dm þ e‚
where e is an error term and the other terms are as before. Note
that by not modeling the nesting there is now scope for the
estimation of a probe term and a separate error term.
For case-control data the factor ci has two levels; case and
control. We arbitrarily set ‘control’ to be the baseline level
with ‘case’ a deviation from this baseline. We can hence refer
to this factor as simply c, the deviation of cases from controls
in the GLMM. Case/control status is treated as ﬁxed in the
linear model whilst strand, probe and array are treated as
random. Estimation for the GLMM is by restricted maximum
likelihood (10).
The nested model allows estimation of the contribution of
the variance components tothe pooling allele frequencyestim-
ate p (11). We focus our attention on just the case samples for
estimation of the variance components. We chose to look only
at cases here for simplicity; the results in the control sample
would be expected to be similar. Hence in the nested linear
model above we drop the factor for case/control status. The
variance of the allele frequency estimate is decomposed as
follows
~ V Va þ
^ s s
2
r
nr
þ
^ s s
2
s
nr · ns
þ
^ s s
2
e
nr · ns · ne
3
where ~ V Va ¼ ~ p pað1   ~ p paÞ/2na is the binomial sampling variance
in cases only, ^ s s
2
r and nr are estimated variance component and
repeat count for replicate (similarly for sense and probe). To
obtain estimates of the variance contributions to the difference
in allele frequency estimates between cases and controls, we
double the estimates for the contribution to p.
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for the case/control factor. ^ c c is analogous to the estimate of
  p pa    p pu from a t-test (where   p pa and   p pu denote the mean values
of p in the case and control pools, respectively). If we were to
drop the random effects other than the error term from the
model we would recover a basic t-test which ignored the
structure of the array data. If in practice, some of the probes
fail and there are (e.g.) only probe measures available on one
DNA strand for a particular SNP, the random effect for strand
is dropped from the model. We show in appendix 2 that the
GLMM case/control estimate c (or in the simpler t-test case,
  p pa     p pu) can be used to estimate var(epool 1). This allows
construction of a test statistic with good statistical properties.
Data application
Case control sample. DNA pools were constructed from 384
endometriosis cases and 384 ethnically matched controls
(8). DNA concentrations were measured using PicoGreen
(Molecular Probes) for the quantitation of double-stranded
DNA in solution on a Fluoroskan Ascent CF plate reader
(Labsystems, Chicago). Concentrations of DNA samples
were carefully adjusted by serial dilutions to a ﬁnal concen-
tration of 25 ng/ml( MS D¼ 25.19 ± 0.55). Individual DNA
samples were tested in at least two PCR to ensure samples
containing high quality DNA.
Array data.SNPs were genotyped on DNA pool samples using
Affymetrix Genechip  HindIII arrays. Arrays were treated
according to standard protocols (Affymetrix, San Diego).
The arrays yield multiple measures of ﬂuorescent intensity
with each giving up to seven probe measures on both the
sense and anti-sense strand of the DNA. In practice, the
10 best probes (from a possible 2 · 7 ¼ 14 per array, counting
both strands) are selected by Affymetrix for inclusion in the
data supplied toend users[(12),SupplementaryData]. Insome
cases there were up to seven probe measures on one strand
of the DNA (in this case the other strand would have a max-
imum of three probe measures) and this necessitated the use of
seven levels in the factor for probe position (i.e. for term d in
the linear model). Single pools of 384 case and 384 control
samples were constructed and aliquots of each pool were
hybridized to three replicate arrays. The maximum possible
number of intensity measures was 5 · 2 · 3 ¼ 30 per sample
(case or control).
The intensity measures consist of perfect-match/mis-match
pairs for each allele. Corrected perfect-match values are cal-
culated by subtracting the average mis-match value (across the
two alleles) from the perfect-match value for each SNP. The
corrected perfect-match values for each allele is used to cal-
culate the proportion, p, of A alleles in the pool for each SNP.
The intensity measures for alleles A and B are known to vary
due to differential hybridization between SNPs. This is ana-
logous to the situation where the differential ampliﬁcation
occurs with previous genotyping technologies; this is typically
addressed by estimating k, the A:B ratio in heterozygotes
(13,14). Although the unequal hybridization adversely affects
allele frequency estimates in single pools the primary interest
here is in the difference in frequency between case and control
pools.Previous work has shown that there isa negligible effect
of the changing values of k on differences in frequency in the
majority of cases [(5,15,16), see also Discussion]. What is
affected however, is the type I error of a naive test statistic
based on the difference between pool frequencies in cases and
controls. We deal with this problem in the statistical method
described above. To calculate the proportion of A alleles in
the pool we use p ¼ A=A þ B (i.e. we assume k ¼ 1). By
not requiring an estimate of k from individually typed hetero-
zygotes, our method has the potential to substantially reduce
the cost of pooling experiments based on large numbers
of SNPs.
A quality control step was implemented in the analysis to
ensure both perfect-match intensities always exceeded the
average of the mis-match intensity over the two alleles. The
maximum number of p values for any SNP was 30. A small
proportion of SNPs (1.3%) had less than 8 p measures
available and these SNPs were removed from the analysis.
Preliminary analysis showed that results based on fewer
than eight intensity measures were particularly unreliable.
A total of 56 494 SNPs, each with between 8 and 30 p meas-
ures, were taken forward into the full analysis.
RESULTS
The estimates of var
p
ðepoolÞ for the GLMM and t-test estima-
tion methods are given in Table 1. Estimates are given on
the standard deviation scale. On the variance scale the
var(epool 1)i s’ 0.00058 irrespective of the estimation
method. Note that although the estimates of var(epool 1)i n
Table 1 are similar for the different estimation methods, the
test statistics calculated on the basis of this value of
var(epool 1) will vary because the estimate of ^ c c is different
for the different estimation methods. The calculation of
var(epool 2) takes into account the precision of the estimate
of ^ c c for each SNP (which varies by estimation method) and so
the estimates of var(epool 2) vary depending on the estima-
tion method used. Var(epool 2) is always smaller than
var(epool 1), since var(epool 1) includes the error involved
in estimating the pool frequency difference (i.e. ^ c c) from the
available probes. The estimate of the total variance associated
with pooling is either var(epool 1) (this averages over the vary-
ing precision of estimates over SNP and hence applies to all
SNPs) or varðepool 2Þþvarð^ c cXÞ (this is speciﬁc to a particular
SNP, in this case to SNP X).
Use of the nested model allows estimation of the contribu-
tion of the different sources to the variance of the pooling
allele frequency estimate. We focus here on the results for
the case sample but the control sample results are similar (data
not shown). With no missing data for three replicates of the
Table 1. Estimation of
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
varðepoolÞ
p
by estimation method
Estimation method
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
varðepool 1Þ
p ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
varðepool 2Þ
p
t-test 0.0241 0.0060
Nested GLMM 0.0241 0.0112
Non-nested GLMM 0.0239 0.0152
Seeappendix1forthedefinitionofvar(epool 1)andappendix2forthedefinition
of var(epool 2). By construction var(epool 2) must be smaller than var(epool 1).
var(epool 1) gives an approximate estimate of the overall variance associated
with pooling; this estimate averages over all SNPs without taking into account
the differing precision (i.e. number of functioning probes) available for
each SNP.
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missing data variance component estimates are computed by
calculating a weighted mean where the weights depend on
the number of probe measures available for that SNP. The
weighted mean variance component estimates for replicate,
strand and probe (across all 56 494 SNPs) are given in Table 2.
Also given in Table 2 is the approximate contribution of such
components to the variance of the pooling allele frequency
estimate. For convenience these are given both as variances
and as standard deviations. The estimate of the contribution of
each source of variance to the difference in allele frequency
between cases and controls is twice the values given in
Table 2. For example, the contribution to the difference in
allele frequency from variation at the ‘probe’ level is
2 · 0.00044 = 0.00088. The contribution from variance at
the ‘strand’ level is of similar magnitude, with the ‘replicate’
variance contributing relatively little variance. In practice, all
three variances would be reduced by simply increasing the
number of replicate arrays applied to each pool. In addition
to reducing variance by increasing array replication, if it is
possible to obtain arrays with larger number of probe meas-
ures per strand then this would lead to useful decreases in
variance. Note that since the maximum likelihood estimation
procedure cannot yield negative estimates of the variance
components, the variance component estimates in Table 2
will be upwardly biased. For many SNPs the estimates for
one or more of the variance component estimates was on
the boundary of the parameter space (i.e. at 0). This means
the upward bias may be substantial.
The results from the available tests for differences between
cases and controls are given in Table 3. Although we know
the t-test based statistics are not optimal, the results of these
are given for comparison. The GLMM based statistics are
computed for the nested and the non-nested case. We also
computed the GLMM based statistics with the factors for
strand and array replicate regarded ﬁrst as ﬁxed and then as
random. Only the random effect results are given here; the
results with strand and array as ﬁxed effects are very similar.
Since we are not interested in the speciﬁc values of these
factors they are most reasonably modeled as random draws
from a population of factor values (i.e. as random effects). We
are interested in directly testing the effect of case/control
status so this factor is treated as a ﬁxed effect.
Since we expect the vast majority of the 56 494 SNPs not to
be associated with disease we would expect the proportion of
SNPs that reach signiﬁcance at the a ¼ 1% level to be very
close to 1%. Table 3 shows that the uncorrected test statistic
has a grossly inﬂated type I error. The type I error of the
corrected t-test based statistics is a substantial improvement
compared with the uncorrected statistic but the type I error
remains signiﬁcantly (P < 0.0001) higher than the level expec-
ted by chance (under the null hypothesis of no association).
The type I error of the nested GLMM (T2 nested) is slightly
above (P ¼ 0.01) the level expected under the assumption of
no true positives. The type I error of the non-nested GLMM
(T2 non-nested) is at the level expected under the assumption
of no (or only a few) true positives.
In Table 4 the proportion of the SNPs exceeding the a ¼
0.1% level are shown. In this case the proportion of SNPs
exceeding the nominal level is slightly higher than expected
for the GLMM (assuming no true positives). The 95% con-
ﬁdence interval (CI) on the number of SNPs exceeding the
0.1%levelassumingnotrueassociationsis(43,71).Theestim-
ates of the number of SNPs reaching this level of signiﬁcance
(69 with the non-nested GLMM, 81 with the nested GLMM)
are around the upper end of this CI, suggesting there may be a
few SNPs that are truly associated in this sample.
There was considerable (but not complete) overlap between
the SNPs identiﬁed by the different statistics. Of the 69
SNPs signiﬁcant at the 0.1% level with the non-nested
GLMM, 54 also appeared in the list of those exceeding the
0.1% level for the nested GLMM (i.e. 54 of the total set of
81 SNPs shown in Table 4). For T1 (t-test based) the overlap
was 52 (i.e. 52 of 162 from Table 4 overlapped). For T2
(t-test based) the overlap was 46 (i.e. 46 of 91 from
Table 4 overlapped). In the last two cases (t-test based stat-
istics) the type I error was inﬂated. This means that the actual
overlap for the last two cases is likely to be slightly less than
the values given here.
Graphs of the observed test statistic against the test statistic
expected under a c2
1 distribution are shown in Figure 1. This
ﬁgure clearly shows the inappropriate type I error for the
uncorrected and t-test based test statistics.
Table 2. Variance component estimates from nested model (case sample only)
Replicate Strand Probe
Variance component (as variance) 0.00026 0.00268 0.01054
Variance component (as standard deviation) 0.01612 0.05176 0.10266
Contribution to variance in allele
frequency estimate (as variance)
0.00009 0.00044 0.00042
Contribution to variance in allele
frequency estimate (as standard deviation)
0.00931 0.02097 0.02049
The first two rows give the variance component estimates for each source (as
variance and as standard deviation). These values are then inserted into
Equation 3 to give the contribution to the variance in allele frequency estimate
(variance/standard deviation given in last two rows).
Table 3. Test statistic comparison at 1% level
Test statistic # SNPs
exceeding
1% level
Proportion
exceeding
1% level
Tsimple (t-test based, uncorrected) 9370 0.16580
T1 (t-test based) 734 0.01299
T2 (t-test based) 666 0.01179
T2 (nested GLMM) 620 0.01097
T2 (non-nested GLMM) 554 0.00981
ThetotalnumberofSNPsis56494.Thenumberexpectedtoexceedthe1%level
under the null hypothesis of no true associations is 565.
Table 4. Test statistic comparison at 0.1% level
Test statistic # SNPs
exceeding
0.1% level
Proportion
exceeding
0.1% level
T1 (t-test based) 162 0.00287
T2 (t-test based) 91 0.00161
T2 (nested GLMM) 81 0.00143
T2 (non-nested GLMM) 69 0.00122
The total number of SNPs is 56 494. The number expected to exceed the 0.1%
level under the null hypothesis of no true associations is 56.
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We have described a structured analysis method using internal
replication information in large scale genotyping sets. The
proposed method takes advantage of information from
SNPs typed in parallel (typically on an array) to construct a
test statistic with appropriate type I error. The method does not
require the use of additional arrays for the estimation of
unequal hybridization rates. As a result, the method can be
applied with very few arrays. In our sample of 384 endomet-
riosis cases and controls, we were able to obtain good results
with a total of only six arrays.
In the optimal case, the difference between cases and
controls was estimated using a GLMM. This approach differs
from that taken by other authors in that the nested structure of
the data are taken into account. In contrast, the Affymetrix
GDAS software utilizes the median intensity score (across
sense and strand measures) to evaluate the allele frequency
in a pool (12). One of the main advantages of the median,
compared with say the mean, is the robustness to outliers. To
test whether outliers were having a large effect on the results
that we obtained we recalculated the GLMM based test stat-
istics on a dataset where the largest and smallest probe meas-
ures were removed from the data; this resulted in a dataset,
which contained estimates of allele frequency differences
based on between 6 and 28 probe measures. The results
were very similar to those obtained on the full dataset (data
not shown), indicating that outliers were not having a substan-
tial effect on our results.
There are many disadvantages in using the median. Firstly,
an analysis based on the median will not take into account the
structure of the probe measurements. Secondly, the median
discards information on the precise magnitude of the actual
observations and typically has greatly increased sampling
variance compared with the mean (9). Finally, there is no
computationally rapid method of evaluating the standard
error of the median. This ﬁnal disadvantage is particularly
unfortunate in the context of the work presented in this
paper because the method we describe works best when the
corrected test statistic takes into account the variable precision
present when estimating the allele frequency differences from
variable numbers of probes.
In the linear model we have assumed that the response
variable (p) was unbounded when in reality it is bounded
by 0 and 1. In practice, most of the p values of interest are
in the range 0.1–0.9 (i.e. minor allele frequency or MAF > 0.1)
and the bounding will not affect the results greatly. For loci
with smaller MAF the model would be less appropriate and a
model which explicitly dealt with frequency data (e.g. a gen-
eralized linear model with a logit link function) would give
better results. In practice, for loci with small MAF, the power
to detect the disease loci would be greatly decreased
(compared with loci with larger MAF). This lack of power
is likely to impact on results more than the inadequacy of the
model for low MAF loci.
We employed two different linear models for the structure
of the array data. The nested model has the advantage of
allowing estimation of the different components of variance
that contribute to the variance in the allele frequency estimate
[see Table 2 and (11)]. The non-nested model does not
explicitly model the nested structure of the data but has the
advantage of allowing estimation of an overall error term in
addition to terms for replicate, strand and probe (there are not
Figure 1. Comparisonofteststatisticperformance.Resultsfor56494SNPs.Eachstatisticisplottedagainsttheexpecteddistributionunderthehypothesisthatthere
areno(orveryfew)truepositives.Ateststatisticwithdistributionexactlyequaltotheexpectedasymptoticdistributionwillliealongtheplottedy¼xline.Theplotted
lines exhibit considerable stochastic variation at high values (>18) because there are few data points in this range.
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when a nested model is used). Having a separate term for
probe is desirable because this allows the structure of the
probe measurements to be modeled. For example, level 1 of
the probe factor (which corresponds to a probe quartet with a
central interrogation position on Affymetrix HindIII arrays
[(12), Supplementary Data] is assumed to be the same across
different replicates and strands. Similarly for factor levels 2,
3,...(which correspond to up and downstream interrogation
positions on Affymetrix HindIII arrays).
Using the nested linear model allowed us to evaluate the
different sources of variation for the variance in estimate of
allele frequency (Table 2). In practice the interest is often in
the difference in allele frequency between cases and controls.
The contribution of each of the sources to the variance of the
difference in allele frequency in cases and controls is twice the
values given in Table 2. That is, we can rewrite equation 3 to
now represent the variance associated with the difference in
allele frequency between cases and controls;
~ V V þ 2
^ s s
2
r
nr
þ
^ s s
2
s
nr · ns
þ
^ s s
2
e
nr · ns · ne
 !
4
where ~ V V is the binomial sampling term for the difference in
allele frequency (i.e. not for simply the allele frequency).
Evaluating ^ s s
2
r=nr þ ^ s s
2
s=ðnr · nsÞþ^ s s
2
e=ðnr · ns · neÞ gives
a value of  0.00089. In the absence of errors in estimation
^ s s
2
r=nr þ ^ s s
2
s=ðnr · nsÞþ^ s s
2
e=ðnr · ns · neÞ should equal
var(epool 1) (to see this compare equations 4 and A1). In prac-
tice var(epool 1) yields a value of 0.00058. This indicates that
the estimate of ^ s s
2
r=nr þ ^ s s
2
s=ðnr · nsÞþ^ s s
2
e=ðnr · ns · neÞ
has been inﬂated by the maximum likelihood estimation
procedure. Because of the way it is calculated (from the
mean of ^ c c
2 values over all SNPs), the estimate of var(epool 1)
is unlikely to be subject to the same biases and is likely to
be a more reliable estimate.
In our experiment we generated array replicates by using
replicate arrays on the same pool. An alternative approach
would be to use replicate arrays on replicate pools. In the
former case there would be ‘technical’ variance as a result
of differences between arrays. In the latter case there would be
both ‘technical’ variance and ‘pooling construction’ variance.
When we applied the nested model to the case only sample we
obtained estimates of the variance from different sources (see
Table 2); the estimate for the replicate variance would only
reﬂect the ‘technical’ variance and not the ‘pooling construc-
tion’ variance. To gain an estimate of both the ‘technical’ and
the ‘pooling construction’ variance in a single sample one
would need to perform an experiment with replicate arrays
on replicate pools [e.g. as done by Brohede et al. (2)]. How-
ever, if one is only interested in the difference between cases
and controls, we would expect the method described in
appendix 2 to do a reasonable job of taking into account
both the ‘technical’ variance and the ‘pooling construction’
variance. To see this consider the way in which var(epool)
is estimated (appendix 2). The estimate of var(epool) is calcu-
lated on the basis of case-control differences and will hence
include both sources of variance. This assumes that the vast
majority of SNPs are not associated with disease and that
for virtually all SNPs the ‘cases’ and ‘controls’ are just an
independently constituted pool/sample. Since this is likely to
be a reasonable assumption, the estimate we obtained for
var(epool)( ’0.00058) is unlikely to be substantially inﬂated.
Since we expect the vast majority of SNPs not to be asso-
ciated with disease in this sample, the corrected test statistics
should follow a c2
1 distribution for most of the observed range.
This occurs for the GLMM test statistics, with the only devi-
ation occurring at the upper end of the test statistic range.
Although it is difﬁcult to reliably discriminate between true
and false positives, the GLMM test statistics are consistent
with there being a few real positives. To further evaluate this
we added 10 ‘real’ positives (where 10 randomly chosen
points from the top decile had 10 added to their test statistic)
to a set of 56000 data points from a c2
1 distribution. Plotting
these in a similar way to the test statistics shown in Figure 1
reveals a picture very similar to that seen for the GLMM
results (data not shown).
The method described here does not use information on
the difference in peak heights in a heterozygote individual
(k). Although k can be estimated given data on individually
genotyped heterozygotes, such a procedure adds to the cost of
a pooling experiment, particularly given that our method
allows users to reliably conduct a whole pooling experiment
with only a few arrays per sample. In the near future associ-
ation studies will be based on several hundred thousand SNPs
and reliable estimation of k for every SNP will be difﬁcult to
co-ordinate. The effect of k has been considered by a number
of authors (5,8,16,17). Although assuming k is 1 when it is not
known to lead to biases, such biases are greatly diminished
whenpooling isused for case-control studies because the same
error in the speciﬁcation of k is made in both pools. The effect
of k on power was considered in depth by Moskvina et al. (16).
Moskvina et al. (16) derive a statistic, kmax, which gives the
value of k for which statistical power is maximized. The kmax
values for a range of case (columns) and control (rows) fre-
quencies are given in Table 5. Note that the kmax values are not
entered in the diagonal cells of Table 5 as these correspond to
the case of no difference in frequency between cases and
controls. Clearly, when kmax is close to 1 (cells with boldface
in Table 5) then assuming k ¼ 1 will not lead to appreciable
losses in power. The only occasions in which kmax deviates
substantially from 1 are those when the minor allele frequency
of either cases or controls is around 0.1 (cells with italic font in
Table 5). Unfortunately, these cases are also the cases in which
Table 5. kmax values at varying frequencies in cases and controls
Frequency
case/control
0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
0.1 0.17 0.22 0.27 0.33 0.41 0.51 0.67 1
0.2 0.17 0.33 0.41 0.5 0.61 0.76 1 1.5
0.3 0.22 0.33 0.53 0.65 0.8 1 1.31 1.96
0.4 0.27 0.41 0.53 0.82 1 1.25 1.63 2.45
0.5 0.33 0.5 0.65 0.82 1.22 1.53 2 3
0.6 0.41 0.61 0.8 1 1.22 1.87 2.45 3.67
0.7 0.51 0.76 1 1.25 1.53 1.87 3.06 4.58
0.8 0.67 1 1.31 1.63 2 2.45 3.06 6
0.9 1 1.5 1.96 2.45 3 3.67 4.58 6
kmaxvaluesbetween0.5and2areinboldface,kmaxvaluesintherange(0.2–0.5)
and(2,5)areinnormalfontandkmaxvalueslessthan0.2orgreaterthan5arein
italic font.
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individuals must be screened to ﬁnd a suitable number of
heterozygotes).
For a small subset of the data (74 SNPs) we had access to
high precision estimates of k from a sample of  3000 indi-
viduals described in Craig et al. [(18), Supplementary Data].
These allowed us to assess the impact of assuming k ¼ 1 in our
main analysis. The estimates of k were used to recalculate the
allele frequency differences from the raw intensity scores and
test statistics (and their associated P-values) were calculated
using the method described in the Materials and Methods
section (based on the nested GLMM but the non-nested
GLMM gives very similar results). The P-values were
converted to  log10(p) for comparison between the k ¼ 1
denoted pk¼1) and k 6¼ 1 (denoted pk6¼1) cases. The correlation
between the two was very high (>0.98 for correlation between
 log10 transformed values, >0.99 for correlation between
untransformed values). Figure 2 shows the regression of
 log10(pk6¼1)o n log10(pk¼1).The equationof the regression
line (drawn on Figure 2) was 0.000 + 0.989 · (  log10(pk¼1))
with standard errors of 0.013 and 0.021 for the estimates of
intercept and slope, respectively. The vast majority of the
points in Figure 2 fall very close to the line y ¼ x (for clarity
the line y ¼ x is not included in Figure 2 as it is almost
indistinguishable from the estimated regression line). These
results indicate that even if reliable estimates of k were avail-
able, this would have a negligible effect on the results shown
here. Including k may also cause problems if the sample of
individually genotyped individuals is small since the error in
estimating k will be substantial. This error must be taken into
account in any method which does not use substantial numbers
of individuals to estimate k. Although some efforts have been
made to centralize the estimation of k values from suitably
large samples (1), estimation of k from large numbers of
individuals is the exception rather than the norm to date
(13,15,17). Furthermore, it is unclear how comparable estim-
ates of k are across different platforms. The recent HapMap
paper reported that there was considerable inconsistency
between different SNP typing platforms, with fewer than
20% of HapMap SNPs being successfully typed by all of
the tested platforms (19), Supplementary Data]. Methods
which do not require estimates of k will be preferable when
there is doubt about the transferability of results across plat-
forms. When reliable estimates of k are available e.g. from the
resource described in (1)], they can be simply incorporated
into the analysis we describe here. A modiﬁed version of the
scripts to implement our method with k estimates is available
on request.
For SNPs with minor allele frequency >0.1 the binomial
sampling standard deviation [i.e. V
p
, where V ¼ pa(1   pa)/
2na + pu(1   pu)/2nu for a 384 individual sample is in the range
(0.015–0.025)]. The standard deviation of the estimate of
allele frequency difference (c) between cases and controls
had interquartile range (25th–75th percentile) of (0.018–
0.028) for the data examined here (using non-nested
GLMM estimates). In the quality control stage of the analysis
we discarded SNPs for which there were not at least eight
probe measures per pool. If we set a much more stringent
criteria for inclusion (>20 probes, resulting in half of all
SNPs being discarded), the interquartile range was not sub-
stantially smaller (0.018–0.026). Alternatively, if only two
arrays per sample were available (8–20 probes per sample),
this interquartile range increased to (0.022–0.035). Increasing
the number of arrays would decrease the error in allele fre-
quency difference estimation. However, the ﬁxed size of the
binomial sampling variance means that the return from
increasing the number of arrays will be diminished with
more than a handful of arrays per sample. For the variance
correction method we describe above, only using one array
(restricted to the case where we had 6–10 probes per array)
per sample was insufﬁcient to recover a (GLMM corrected)
test statistic with appropriate type I error (i.e. the estimate of
var(epool) was not sufﬁciently accurate). With two arrays the
type I error with the GLMM corrected test statistic was accept-
able (although a larger number of arrays may be required for
good power, see below).
The error involved in estimating the allele frequency
difference in pools will lead to a loss of power. Using the
estimate of var(epool) based on var(epool 1)( ’0.00058) we
can calculate the approximate effective sample size if the
same sample were individually genotyped. Equation 2 gives
an expression for the effective relative sample size (ERSS) as
~ V= V=ð~ V V þ 2varðepool 1ÞÞ (5). We assume here that the allele
frequency ’1/2 and the number of cases and controls is
384; this gives ~ V V ¼ 0:00065. Multiplying ERSS by the sample
size gives the effective sample size (ESS). For the array data
presented here, the ERSS is  ð0:00065Þ=ð0:00065þ2·
0:00058Þ or ’1/3 that of an individually genotyped sample.
With 10 arrays the ERSS would be ’1/2. Increasing the ERSS
to 2/3 would require  40 arrays. Note that distributing the
available arrays across sub-pools instead of a single large pool
will not affect the ERSS. Increasing the number of sub-pools
by a factor f increases ~ V V by a factor f
p
but assuming that the
total number of arrays is ﬁxed, the number of arrays per sub-
pool will decrease by f, resulting in an increase in var(epool)b y
Figure 2. Comparison of log transformed P-values calculated assuming k ¼ 1
with logtransformedP-valueswhere k was estimatedfrom  3000 individuals.
Datafrom74SNPsareshown.Theregressionline,y¼0.000+0.989·isdrawn
ontheplot.Theliney¼xisnotshownbutisvirtuallyindistinguishablefromthe
regression line.
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p
. Since these cancel in f
p ~ V V=ð f
p ~ V Vþ
2 f
p
varðepool 1ÞÞ using say 12 arrays on 384 individuals yields
the same ERSS as using 6 arrays on each of two sub-pools of
192 individuals.
In practice the most effective study design will vary
depending upon whether the total number of individuals is
ﬁxed. If the total is not ﬁxed, greater efﬁciency (in terms of
ESS) can be achieved by allocating fewer arrays to larger
numbers of individuals. For example, if the limiting factor
is that 48 arrays are available, the ESS with 384 individuals
typed with 24 arrays per sample (case, control) is
384 · ð0:00065=ð0:00065 þ 2 · 0:00058 · 3
24
p
¼ 235ÞÞ.I n
comparison with 2 · 384 ¼ 768 individuals typed on 12 arrays
per sample the ESS equals 406. With 4 · 384 individuals and
six arrays per sample the ESS equals 679. Note that, as dis-
cussed above, we recommend that at least two arrays are typed
per sample to allow accurate estimation of var(epool).
Study design in conventional (not array based) pooling
studies was examined by Barratt et al. (11). They assessed
different possible designs with the cost of the different stages
of the pooling experiment factored into a cost efﬁciency
calculation. For the scenarios they consider, cost efﬁciency
is maximized with two sub-pools instead of one large pool
[Figure 3 in Barratt et al. (11)]. Although the relative sample
size increases with increasing numbers of sub-pools, the total
cost of the experiment also increases. A detailed examination
of the cost efﬁciency (factoring in the cost of the arrays,
sample preparation and so on) of an array based study
would be an interesting area for further study.
We have focused our attention on pooling in case-control
samples. Although the simplest application of pooling is to
such samples, pooling has previously been applied to datasets
where the trait of interest was quantitative (20,21). In such
circumstances there is no simple way of ‘canceling out’ the
effect of k because the statistical test does not simply involve
the difference between two groups. The importance of gaining
an appropriate estimate of k would hence be increased com-
pared with the case-control situation we address here.
Based on the results we have obtained some recommenda-
tions can be made. Firstly, we recommend investigators do not
expend resources on obtaining estimates of k from their own
data. At least in the context of case-control studies, funds
should instead be spent on replicating arrays in pools and
on replicating results with pools across independent samples
of cases and controls. When reliable estimates of k are avail-
able they can of course be included but the results are unlikely
to change substantially compared with the situation where k is
taken to be 1. We recommend the use of suitably large
numbers of replicate arrays when pooling DNA from large
numbers of individuals. With 384 individual samples, up to
10 times replication would give reasonable value for money in
terms of increase in power. With smaller samples, the need for
replication is decreased. For example with 96 individuals
per pool, three arrays would be sufﬁcient to obtain reasonable
power; the ERSS would be ’1/2 with three arrays if var(epool)
was similar to the value we observed in our endometriosis
data.
We have described a method for screening SNPs from
arrays on DNA pools in case-control association studies. By
estimating the pooling variance from parallel typed SNPs the
method minimizes the number of arrays required. This will
facilitate large scale association analysis of suitably large
samples at a cost well within the reach of most laboratories.
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APPENDIX 1
With pooled data, the sample allele frequency is subject to
pool speciﬁc error in addition to the usual binomial sampling
error. The sample frequency estimate, ~ p pa(for cases, for con-
trols replace a with u), from pooled data can be written
~ p pa ¼ ^ p pa þ epool 1 ¼ pa þ eb þ epool 1
where pa is the true population frequency, eb is the binomial
sampling error and epool 1 is the error associated with estim-
ating the frequency from the pool (5). This implies that
varð~ p pa   ~ p puÞ¼V þ 2varðepool 1Þ A1
and
EðTsimpleÞ¼
Eð~ p pa ~ p puÞ
2
varð^ p pa  ^ p puÞ
¼
V þ 2varðepool 1Þ
V
and that a corrected test statistic is
T1 ¼ Tsimple ·
V
V þ 2varðepool 1Þ
In practice we cannot calculate V and we substitute ~ V V for V.
APPENDIX 2
The aim here is to construct a corrected statistic for asso-
ciation testing. First we calculate the value of the GLMM
case/control estimate and square it (i.e. we compute ^ c c
2) for
each SNP. If a simple t-test was applied to the array data
instead of the GLMM we would have ^ c c
2 ¼ð   p pa   p puÞ
2.
Since the mean of ^ c c
2 over all SNPs provides an estimate of
varð~ p pa  ~ p puÞ we may obtain an estimate of var(epool 1)b y
re-arranging equation A1 from the appendix 1 as follows
varðepool 1Þ¼
1
2
ðvarð~ p pa   ~ p puÞ ~ V VÞ’
1
2
ðmeanð^ c c
2Þ ~ V VÞ
¼
1
2
meanð^ c c
2   ~ V VÞ
Note again that ~ V V is again in practice substituted for V. This
allows the calculation of the test statistic in equation 2. This
new test-statistic will be substantially less anti-conservative
than Tsimple but will remain slightly anti-conservative because
it fails to take into account the varying precision with which
the allele frequencies are estimated. With array data, differing
numbers of intensity measures will be used to calculate the
GLMM case/control estimate (c) for each SNP so there will
typically be variation in the precision of the estimates from
SNP to SNP. We re-write equation A1 to take into account this
error as follows
varð~ p pa   ~ p puÞ¼~ V V þ 2varðepool 2Þþvarð^ c cÞ
where varð^ c cÞ is the square of the estimated standard error
(e.s.e.) of the GLMM case/control estimate ^ c c. Given the linear
model speciﬁed above this e.s.e. is obtained from the square
root of the relevant diagonal element (i.e. the element corres-
ponding to the ﬁxed effect c) of the inverse of the information
matrix in a GLMM. This e.s.e. is available in the output of
GLMM packages, such as ASReml (http://www.vsn-intl.com/
ASReml/). This in turn provides us with a new estimate for the
error associated with estimating the frequency from the pool
varðepool 2Þ¼
1
2
meanf^ c c
2   ~ V V   varð^ c cÞg
The new corrected test statistic now requires correction for the
overall var(epool) term and for the SNP speciﬁc varð^ c cÞ term.
The test statistic for a given SNP, say X [with estimated
variance varð^ c cXÞ], is hence
T2 X ¼ Tsimple ·
~ V V
~ V V þ 2varðepool 2Þþvarð^ c cXÞ
Note that var(epool 1) will typically be larger than var(epool 2).
Note also that, since the correction in T2 corrects for a portion
of variation that is speciﬁc to that SNP, T2 should be more
accurate than T1.
The test statistics above can be calculated using R (http://
www.r-project.org/) and ASReml. Scripts which implement
the above method are available on request from the corres-
ponding author.
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